Navigation Links
XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
Date:6/11/2009

r the historical information contained herein, the matters set forth in this press release, including the description of the company and its products offerings, are forward-looking statements within the meaning of the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the historical volatility and low trading volume of our stock, the risk and uncertainties inherent in the early stages of growth companies, the company's need to raise substantial additional capital to proceed with its business, risks associated with competitors, and other risks detailed from time to time in the company's most recent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements.

        Investor Relations
        David Elias
        516-967-0205


'/>"/>
SOURCE XELR8 Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007
2. XELR8 Holdings Announces Fiscal 2007 Financial Results
3. XELR8 Holdings Announces Record First Quarter Revenue
4. XELR8 Holdings Announces Continuation of XELR8 To A Million Promotion
5. XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results
6. XELR8 Holdings, Inc. Announces Fourth Quarter and 2008 Annual Financial Results
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
9. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
10. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
11. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Thirteen Novant Health ... Great 100 Nurses in North Carolina list ... excellence and provides scholarships to nursing students at all ... Novant Health Presbyterian Medical Center are: Rea ... Nora King, Lissa Ready, Amber Segerlin, Carmen Smith, Melissa ...
(Date:8/29/2014)... By Steven Reinberg ... (HealthDay News) -- The vast majority of American babies ... from serious illnesses, federal health officials said Thursday. ... vaccines that prevent measles, mumps, and rubella (MMR); polio; ... Centers for Disease Control and Prevention. "Nationally, vaccination ...
(Date:8/29/2014)... study from the research group of Dr. John Lewis at ... Research Institute (London, ON) has confirmed that "invadopodia" play a ... in Cell Reports , shows preventing these tentacle-like structures ... , Roughly 2 in 5 Canadians will develop cancer in ... of the disease. In 2014, it,s estimated that nine Canadians ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Floors of ... especially when wearing socks. Also, many patients are relegated ... poor balance, surgery recovery, Alzheimer’s, etc. Two inventors from ... to optimize patient safety. , This special pair of ... It also keeps patients who are relegated to beds ...
(Date:8/29/2014)... University School of Medicine have identified one way the ... insight that could lead to new therapies, in ... Host & Microbe . , In work performed at ... the researchers developed a detailed map of how a ... that takes signaling molecules in and out of the ...
Breaking Medicine News(10 mins):Health News:Great 100 Honors 13 Novant Health Nurses 2Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Preventing cancer from forming 'tentacles' stops dangerous spread 2
... VILLAGE, Calif., Jan. 21 Specialists On Call,Inc. ... operations and,business development staff to address the accelerating ... largest provider of emergency neurology on-call,services to hospitals, ... to date. , (Logo: ...
... how to avoid most common cause of poisoning in U.S. ... know better, you could confuse carbon monoxide (CO) poisoning with ... has a new fact sheet out to help prevent people ... to the emergency room caused each year by unintentional CO ...
... HAIKOU CITY, China, Jan. 21 /PRNewswire-Asia-FirstCall/ -- ... Board: CPHI), which develops,manufactures, and markets specialty ... preview. , According ... financial year 2008,China Pharma achieved record high ...
... up all over China, more patients will receive dental ... According to Millennium Research Group,s (MRG,s) Chinese ... dental clinics are continuing to emerge in response to ... class and aging population. The establishment of these private ...
... ORLANDO, Fla., Jan. 21 MEDai, Inc., headquartered in ... announced today that has been invited by World Research ... Predictive Modeling for Underwriting Conference. This year,s conference ... on the importance of effectively integrating predictive modeling into ...
... ABT ),today announced financial results for the fourth quarter ended Dec. 31, 2008. ... excluding specified items, were $1.06, ... forecast. Diluted earnings per share under Generally ... were $0.98, up 27.3 percent., -- Worldwide ...
Cached Medicine News:Health News:Specialists On Call Accelerating Access to Emergency Neurology On-Call Services in Texas 2Health News:China Pharma Holdings, Inc., Financial Year 2008 Preview 2Health News:China Pharma Holdings, Inc., Financial Year 2008 Preview 3Health News:Chinese Dental Implant Market Promises Strong Growth 2Health News:MEDai Presents on Transitioning Predictive Modeling Integration From Care Management to Actuarial Applications 2Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 2Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 3Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 4Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 5Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 6Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 7Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 8Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 9Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 10Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 11Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 12Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 13Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 14Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 15Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 16Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 17Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 18Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 19Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 20Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 21Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 22Health News:Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 23
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Multiple Sclerosis Drugs Market 2014-2018" ... is a chronic, inflammatory medical condition that results in ... damaged because of an abnormal response by the immune ... (CNS). It is a potentially debilitating disease in which ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... Ala., Dec. 14 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ... data evaluating forodesine HCl, the Company,s lead anti-cancer,compound, ... and lymphomas., Madeline Duvic, M.D., Deputy Chair, ... presented interim data from the Phase,I/II clinical study ...
... the Treatment of PKU, NOVATO, Calif., Dec. ... announced today that the U.S.,Food and Drug Administration ... Tablets, the first specific drug,therapy approved for the ... will commence tomorrow, and BioMarin will begin,promotion of ...
Cached Medicine Technology:Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 2Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 3Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 4BioMarin Announces FDA Approval for Kuvan 2BioMarin Announces FDA Approval for Kuvan 3BioMarin Announces FDA Approval for Kuvan 4BioMarin Announces FDA Approval for Kuvan 5BioMarin Announces FDA Approval for Kuvan 6BioMarin Announces FDA Approval for Kuvan 7BioMarin Announces FDA Approval for Kuvan 8
Stainless steel construction to withstand sterilization modalities (EtO) Wide angle of view...
Inquire...
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
Medicine Products: